266 related articles for article (PubMed ID: 10911380)
21. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
[TBL] [Abstract][Full Text] [Related]
22. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
[TBL] [Abstract][Full Text] [Related]
23. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
[TBL] [Abstract][Full Text] [Related]
24. CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection.
Garcia Vela J; Delgado I; Benito L; Monteserin M; Garcia Alonso L; Somolinos N; Andreu M; Oña F
Leukemia; 1999 Oct; 13(10):1501-5. PubMed ID: 10516749
[TBL] [Abstract][Full Text] [Related]
25. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
27. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
28. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
29. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
30. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
31. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
[TBL] [Abstract][Full Text] [Related]
32. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
33. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
34. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
DiGiuseppe JA; Borowitz MJ
Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
[TBL] [Abstract][Full Text] [Related]
36. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase.
Bell PB; Rooney N; Bosanquet AG
Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328
[TBL] [Abstract][Full Text] [Related]
37. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody.
Huh YO; Pugh WC; Kantarjian HM; Stass SA; Cork A; Trujillo JM; Keating MJ
Am J Clin Pathol; 1994 Mar; 101(3):283-9. PubMed ID: 8135183
[TBL] [Abstract][Full Text] [Related]
38. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
39. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
Li W; Fang P; Fu G; Liang H; Peng M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
[TBL] [Abstract][Full Text] [Related]
40. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
DiRaimondo F; Albitar M; Huh Y; O'Brien S; Montillo M; Tedeschi A; Kantarjian H; Lerner S; Giustolisi R; Keating M
Cancer; 2002 Mar; 94(6):1721-30. PubMed ID: 11920534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]